Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience-Reference-Cited by-同舟云学术

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience

Published:2019-02-26 Issue:7 Volume:54 Page:660-666
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Ueda Yoshihide^ORCID,Kobayashi Tsuyoshi,Ikegami Toru,Miuma Satoshi,Mizuno Shugo,Akamatsu Nobuhisa,Takaki Akinobu,Ishigami Masatoshi,Takatsuki Mitsuhisa,Sugawara Yasuhiko,Maehara Yoshihiko,Uemoto Shinji,Seno Hiroshi

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-019-01561-1/fulltext.html

Reference21 articles.

1. Liver transplantation in Japan. Registry by the Japanese Liver Transplantation Society. Jpn J Transplant. 2018;53:109–23.

2. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000;32:673–84.

3. Terrault N. Liver transplantation in the setting of chronic HCV. Best Pract Res Clin Gastroenterol. 2012;26:531–48.

4. Ueda Y, Uemoto S. Interferon-free therapy for hepatitis C in liver transplant recipients. Transplantation. 2016;100:54–60.

5. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Patients who develop recurrent HCV infection post liver transplantation. https://www.hcvguidelines.org/unique-populations/post-liver-transplant . Accessed 21 Sept 2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection;Clinical Infectious Diseases;2023-05-25

2. Hepatitis C: treatment;Comprehensive Guide to Hepatitis Advances;2023

3. Liver Transplantation from a Human Leukocyte Antigen-Matched Sibling Donor: Effectiveness of Direct-Acting Antiviral Therapy against Hepatitis C Virus Infection;Reports;2022-12-04

4. Allograft liver failure awaiting liver transplantation in Japan;Journal of Gastroenterology;2022-06-01

5. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27